公司资料
Intelligent Bio Solutions 股价、新闻与催化剂
- 股票代码:
- INBS
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
1.66 USD (-0.60%)
收盘价
最后更新: 2026年10月1日
6.08M USD
市值
股价为何变动
截至 2026年10月1日，INBS 下跌 0.60%，收于 $1.66。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Fingerprint Drug Screening Company
Intelligent Bio Solutions develops rapid, non-invasive drug-testing systems that analyze fingerprint sweat. Its platform is used in workplace and safety-sensitive environments outside the United States.
Intelligent Fingerprinting System
The system combines a disposable collection cartridge with a portable reader and software. A fingerprint sweat sample is collected in seconds, and the reader can provide screening results in under ten minutes.
Drug Detection Menu
Commercial cartridges screen for commonly abused substances including opiates, cocaine, methamphetamine, and cannabis. The company is pursuing an initial U.S. clearance for codeine detection.
Reader-and-Cartridge Model
INBS places or sells readers and generates recurring revenue from single-use cartridges. Growth in the installed base increases the opportunity for repeat consumable sales as customers conduct routine testing.
Workplace and International Markets
Customers include logistics, construction, manufacturing, drug-treatment, and other organizations where impairment creates safety risks. The business is established in the United Kingdom and other markets while preparing for U.S. entry.
未来催化剂
- FDA 510(k) submission for the Intelligent Fingerprinting Drug Screening System in the second half of 2026.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。